Central Jersey Blood Center Inc

Nonprofit profile at a glance

EIN
221769155
IRS 990 coverage
2012–2019
Forms available
Form 990 2019
Location
Summit, NJ, USA
Phone
9089642485
Rating
69
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Blood Supply Related

Official website

Reported finances

Revenue
$410,254
Expenses
$1,818,551
Assets
$0
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2019. Amounts in USD.

Leadership & pay

7 people listed

Executive titles in this filing

  • PASCAL GEORGE (CEO)

Highest reported compensation

  • PASCAL GEORGE (CEO): $281,746 total reported compensation
  • KAREN LEADBEATER (CFO): $150,568 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2019. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

See schedule o for complete mission statement.cjbc was founded with a vision to save lives by providing safe, high quality blood products and services to patients in need. Entrusted to collect, process and distribute this priceless life source, we carry out our mission through the selfless giving of volunteer blood donors; our dedicated and caring staff and volunteers; and our partnership with medical professionals and regulators to ensure the safety of the blood supply and to advance the body of knowledge in blood management. With three blood donor centers in New Jersey, our organization has grown into one of the premier blood centers of nj. We believe that people can give of themselves and make a huge difference in the lives of others.when you donate blood, you can help treat premature babies, burn and trauma victims, patients suffering from leukemia and other cancers, cardiac disease, and many other conditions that depend on blood products for recovery.

What it reported doing in 2019

Processing of blood. The center operates a manufacturing laboratory that is responsible for checking, separating, testing, packaging and distributing blood and blood derivatives to our hospital clients. Our manufacturing services are evaluated by several agencies, including the fda, csl, aabb and states of nj and ny. We are proud to report that our manufacturing process has consistently met and exceed all standards and regulations mandated by these licensing and accrediting organizations. All functions are performed with the highest level of quality as product safety is paramount to our patient population. Operations ceased in 2018 with final lquidation in 2019.

Operating model

Revenue model
Earned-program. 93% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. A relatively small share of total spending goes to programs and expenses are high relative to revenue.

Rating breakdown

  • Financial Efficiency: 70
  • Transparency & Controls: 77
  • Accountability: 91
  • Sustainability: 2
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 100%; rating input score 100
  • Program expense ratio: 42.2%; rating input score 42
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 3 of 6 controls in place; rating input score 50
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Pass
    • Written employment contract: Pass
    • Compensation survey or study: Missing
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 7 of 9 controls in place; rating input score 78
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Pass
    • Other executive compensation review process: Pass
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: -343.3%; rating input score 0; 0th percentile among comparable filings
  • Total-asset coverage ratio: 0; rating input score 1; 1st percentile among comparable filings
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: 23.8%; rating input score 16; 16th percentile among comparable filings

Growth

  • Program expense growth: -8.4% per year; rating input score 0; 16th percentile among comparable filings
  • Revenue growth: -8.6% per year; rating input score 0; 10th percentile among comparable filings
  • Asset growth: -16.7% per year; rating input score 0; 5th percentile among comparable filings

Details

  • Where the money goes: 100% of revenue deployed · 42.2% of spending went to programs
  • Governance: 5 of 5 board members independent · 7 of 9 filing controls reported
  • Programs: 4 filed program accomplishments · $768K in reported program spending
  • Leadership: top reported pay $282K · 7 people listed · 3 of 6 pay-setting controls reported
  • Consistency: 25 of 25 current checks pass
  • Schedules: 5 filed schedules · includes executive pay
  • Filing history: 8 filing years from 2012 to 2019
  • Contacts: How to reach this organization
  • Money network: 2 filed money-flow records
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Financial Efficiency: Program expense ratio scored 42/100.
  • High — Sustainability: Operating margin scored 0/100.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • High — Sustainability: Total-asset coverage ratio scored 1/100.
  • Review — Accountability: Governance controls: Independent financial-statement audit not reported.
  • High — Growth: Asset growth scored 0/100.
  • High — Sustainability: Officer compensation ratio scored 16/100.